Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

Por Chong, Edward, Kalia, Veena, Willsie, Sandra, Winkle, Peter
Publicado no J Nephrol (2014)

Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients

Por Wüthrich, Rudolf P., Chonchol, Michel, Covic, Adrian, Gaillard, Sylvain, Chong, Edward, Tumlin, James A.
Publicado em 2013

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients

Por Floege, Jürgen, Covic, Adrian C, Ketteler, Markus, Rastogi, Anjay, Chong, Edward M F, Gaillard, Sylvain, Lisk, Laura J, Sprague, Stuart M
Publicado em 2014

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

Por Floege, Jürgen, Covic, Adrian C., Ketteler, Markus, Mann, Johannes F.E., Rastogi, Anjay, Spinowitz, Bruce, Chong, Edward M.F., Gaillard, Sylvain, Lisk, Laura J., Sprague, Stuart M.
Publicado no Nephrol Dial Transplant (2015)